 | Up a level |
Hee, Siew Wan, Willis, Adrian, Smith, Catrin Tudur, Day, Simon, Miller, Frank, Madan, Jason, Posch, Martin, Zohar, Sarah and Stallard, Nigel
(2017)
Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov.
ORPHANET JOURNAL OF RARE DISEASES, 12 (1).
44-.
Gamble, CL 
ORCID: 0000-0002-3021-1955, Krishan, Ashma, Stocken, Deborah, Lewis, Steff, Juszczak, Edmund, Dore, Caroline, Williamson, Paula ORCID: 0000-0001-9802-6636, Altman, Douglas, Montgomery, Alan, Lim, Pilar et al (show 5 more authors)
(2017)
Guidelines for the content of statistical analysis plans in clinical trials.
JAMA: Journal of the American Medical Association, 318 (23).
pp. 2337-2343.
Totton, Nikki, Julious, Steven, Hughes, Dyfrig ORCID: 0000-0001-8247-7459, Cook, Jonathan, Biggs, Katie, Coates, Lizzie, Cook, Andrew, Hewitt, Catherine and Day, Simon
(2021)
Utilising benefit-risk assessments within clinical trials-a protocol for the BRAINS project.
TRIALS, 22 (1).
68-.